- Home
- EVGN vs ACXP Comparison
EVGN vs ACXP Comparison
Compare EVGN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- ACXP
- Stock Information
- Founded
- EVGN 1999
- ACXP 2017
- Country
- EVGN Israel
- ACXP United States
- Employees
- EVGN 75
- ACXP N/A
- Industry
- EVGN Agricultural Chemicals
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- ACXP Health Care
- Exchange
- EVGN Nasdaq
- ACXP Nasdaq
- Market Cap
- EVGN 11.3M
- ACXP 8.4M
- IPO Year
- EVGN N/A
- ACXP 2021
- Fundamental
- Price
- EVGN $1.33
- ACXP $0.49
- Analyst Decision
- EVGN Strong Buy
- ACXP Strong Buy
- Analyst Count
- EVGN 1
- ACXP 2
- Target Price
- EVGN $3.50
- ACXP $10.00
- AVG Volume (30 Days)
- EVGN 5.5M
- ACXP 18.6M
- Earning Date
- EVGN 08-21-2025
- ACXP 08-08-2025
- Dividend Yield
- EVGN N/A
- ACXP N/A
- EPS Growth
- EVGN N/A
- ACXP N/A
- EPS
- EVGN N/A
- ACXP N/A
- Revenue
- EVGN $6,765,000.00
- ACXP N/A
- Revenue This Year
- EVGN N/A
- ACXP N/A
- Revenue Next Year
- EVGN $113.18
- ACXP N/A
- P/E Ratio
- EVGN N/A
- ACXP N/A
- Revenue Growth
- EVGN N/A
- ACXP N/A
- 52 Week Low
- EVGN $0.95
- ACXP $0.30
- 52 Week High
- EVGN $6.80
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- EVGN 49.73
- ACXP 51.01
- Support Level
- EVGN $1.26
- ACXP $0.46
- Resistance Level
- EVGN $1.44
- ACXP $0.56
- Average True Range (ATR)
- EVGN 0.11
- ACXP 0.10
- MACD
- EVGN -0.02
- ACXP -0.01
- Stochastic Oscillator
- EVGN 21.62
- ACXP 24.27
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.